The role of vitamin D in prostate cancer

Steroids

Volumn 66, Issue 3-5, 2001, Pages 293-300

  Zhao, Xiao Yan ^a   Feldman, David ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

1 ,25(OH)2D3 (calcitriol); Androgen receptor; Prostate cancer; Steroid; Vitamin D analogs; Vitamin D receptor

Indexed keywords

2BETA (3 HYDROXYPROPOXY)CALCITRIOL; ALITRETINOIN; ANDROGEN; ANDROGEN RECEPTOR; BICALUTAMIDE; CALCIPOTRIOL; CALCITRIOL; CALCITRIOL DERIVATIVE; IMIDAZOLE DERIVATIVE; LEXACALCITOL; LIAROZOLE; MESSENGER RNA; PROSTATE SPECIFIC ANTIGEN; RO 24 2287; RO 24 5531; SEOCALCITOL; UNCLASSIFIED DRUG; VITAMIN D; VITAMIN D DERIVATIVE;

CANCER CELL CULTURE; CANCER INHIBITION; CELL GROWTH; CLINICAL TRIAL; CONCENTRATION RESPONSE; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIMERIZATION; DNA BINDING; DRUG SCREENING; EARLY CANCER; GENE ACTIVATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; HYBRID; LABORATORY; MEDICAL RESEARCH; PROSTATE CANCER; RECURRENT CANCER; REVIEW; TRANSACTIVATION; UNITED STATES; YEAST;

ANTINEOPLASTIC AGENTS; CALCITRIOL; HUMANS; MALE; PROSTATIC NEOPLASMS; VITAMIN D;

EID: 0035342671     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-128X(00)00164-1     Document Type: Conference Paper

References (56)

1. Vitamin D and prostate cancer
2. Cancer Statistics, 2000
3. Carcinoma of the prostate
4. Geographic patterns of prostate cancer mortality; Evidence for a protective effect of ultraviolet radiation
5. Molecular genetics and epidemiology of prostate carcinoma
6. An investigation of the familial aspects of carcinoma of the prostate
7. Is Vitamin D deficiency a risk factor for prostate cancer?
8. Cancer rate differentials between blacks and whites in three metropolitan areas; a 10-year comparison
9. Studies of Japanese migrants. I. Mortality from cancer and other diseases among Japanese in the United States
10. Vitamin D; biosynthesis, metabolism, and mode of action
11. Evidence of alterations of the vitamin D-endocrine system in blacks
12. Vitamin D; metabolism and action
13. Prostate cancer and prediagnostic levels of serum vitamin D metabolites
14. Physiologic basis of endocrine therapy for prostatic cancer
15. Epidemiologic evidence regarding predisposing factors to prostate cancer
16. The androgen receptor in prostate cancer
17. Studies on prostatic cancer. II. The effects of castration on advanced carcinoma of the prostate gland
18. The biology of hormone refractory prostate cancer. Why does it develop?
19. Vitamin D; A modulator of cell proliferation and differentiation
20. Cloning and expression of full-length cDNA encoding human vitamin D receptor
21. The steroid and thyroid hormone receptor superfamily
22. The nuclear vitamin D receptor; biological and molecular regulatory properties revealed
23. 3 receptor-mediated cell cycle arrest and differentiation
24. 3
25. 3 and malignant melanoma; The presence of receptors and inhibition of cell growth in culture
26. Clinical counterpoint; Vitamin D: New actions, new analogs, new therapeutic potential
27. Vitamin D; Anticancer and differentiation
28. 3
29. 3 receptors and actions in human prostate cancer cell lines
30. 3 on primary cultures of human prostatic cells
31. Studies on the human prostatic cancer cell line LNCaP
32. Hormonal regulation of prostate-specific antigen messenger RNA in human prostatic adenocarcinoma cell line LNCaP
33. 3 and 9-cis retinoid acid in LNCaP human prostate cancer cells
34. 3 and 9-cis-retinoic acid act synergistically to inhibit the growth of LNCaP prostate cells and cause accumulation of cells in G1
35. Two mutations identified in the androgen receptor of the new human prostate cancer cell line MDA PCa 2a
36. 3 inhibits the growth of human prostate cancer cells by androgen-dependent and androgen-independent mechanisms
37. Identification of 3′,5′-cyclic adenosine monophosphate response element and other cis-acting elements in the human androgen receptor gene promoter
38. Androgen-induced inhibition of cell proliferation in an androgen-insensitive prostate cancer cell line (PC-3) transfected with a human androgen receptor complementary DNA
39. Increased androgen receptor activity and altered c-myc expression in prostate cancer cells after long-term androgen deprivation
40. kip1 in androgen-induced cell cycle arrest
41. Human prostate tumor growth in athymic mice; inhibition by androgens and stimulation by finasteride
42. Androgen-repressed phenotype in human prostate cancer
43. Two prostate carcinoma cell lines demonstrate abnormalities in tumor suppressor genes
44. 3 in seven human prostatic carcinoma cell lines
45. Phase I/II dose escalation study of liarozole in patients with stage D, hormone refractory carcinoma of the prostate
46. 3 to inhibit growth of DU 145 human prostate cancer cells by blocking 24-hydroxylase activity
47. The vitamin D endocrine system; Manipulation of structure-function relationships to provide opportunities for development of new cancer chemopreventive and immunosuppresive agents
48. Analysis of vitamin D analog-induced heterodimerization of vitamin D receptor with retinoid X receptor using the yeast two-hybrid system
49. 3 are associated with enhanced activation of the vitamin D receptor
50. 3
51. The vitamin D receptor and the syndrome of hereditary 1,25-dihydroxyvitamin D-resistant rickets
52. Editorial/Mini-Review; Vitamin D and prostate cancer
53. Phase II trial of oral 1,25-dihydroxyvitamin D (calcitriol) in hormone refractory prostate cancer
54. 3 (calcitriol)